We previously identified a novel inhibitor of La protein, H11, which inhibited hepatitis B virus (HBV) replication by inhibiting the interaction between La protein and HBV RNA.
infection, 2 and approximately 240 million people worldwide have chronic hepatitis B (CHB) infections. 3 Currently, two classes of agents, pegylated interferon (PegIFN), which stimulates the immune response to HBV, and nucleot(s)ide analogues (NAs), which directly suppress viral replication, are approved for CHB treatment. However, the sideeffects of PegIFN and viral resistance to NAs have limited the application of these agents and thus, reduced the efficacy of therapy for HBV.
Recently, novel direct-acting antiviral agents (DAAs) with excellent efficacy and safety have been developed for the treatment of chronic hepatitis C virus infection; 4 however, due to the high cost of DAAs, PegIFN plus ribavirin (RBV) combination therapy is still recommended in many developing countries, including China. 5 Therefore, the development of novel anti-HBV agents is necessary.
Human La protein is a multifunctional RNA-binding protein involved in RNA metabolism [6] [7] [8] that has been reported to be involved in stabilizing HBV RNA to promote HBV replication. 9 Depletion of La protein has been shown to downregulate HBV mRNA levels in HepG2.2.15 cells. 10, 11 Previously, we found that phosphorylation of Ser366 in La protein contributed to HBV replication and expression. 12 Because of the critical role of La protein in HBV replication, we established a structure-based virtual system to screen for La protein inhibitors with anti-HBV activity, and we identified a novel inhibitor of La protein, H11, which may be used to treat clinical HBV infections. 13 Although H11 was demonstrated to inhibit HBV replication by inhibiting the interaction between La protein and HBV RNA, the mechanism of H11-mediated inhibition remains to be elucidated.
Long noncoding RNAs (lncRNAs) are broadly defined as endogenous cellular RNA molecules longer than 200 nucleotides in length that do not encode proteins. 14, 15 By interacting with RNA, DNA and protein, lncRNAs can regulate gene expression by chromatin modification, modifying transcription and post-transcriptional processing. Evidence has been accumulating that lncRNAs are involved in many biological processes and are associated with many diseases. 14, 16 It has also been shown that lncRNAs are involved in hepatitis viral infections. 17 Because the target of H11 is La protein, which binds RNA and because lncRNAs play important roles in hepatitis viral infections, we hypothesized that lncRNAs may be involved in H11-mediated inhibition of HBV replication. This study aimed to identify differentially expressed lncRNAs and mRNAs associated with H11-mediated inhibition of HBV replication by lncRNA microarray analysis and to validate the involvement of the identified lncRNAs and mRNAs in H11 mediation inhibition by quantitative real-time polymerase chain reaction (qRT-PCR). Cis-and trans-target genes and differentially expressed mRNAs were subjected to bioinformatic analyses to reveal their potential functions. Expression of members of the lncRNA-mRNA network was altered to further investigate the molecular mechanism of H11-mediated inhibition of HBV replication. 
| MATERIALS AND METHODS

| Cell culture and treatment
| LncRNA target prediction
The targets of differentially expressed lncRNAs were predicted by evaluating cis/trans-regulatory effects. LncRNAs and potential target genes were paired and visualized using UCSC gene annotations (http://genome.ucsc.edu/). mRNAs that were located within 10 kbp upstream or downstream of their paired lncRNAs were considered cis-target genes. Trans-acting lncRNAs were predicted based on mRNA sequence complementarity using BLAST software. Then, RNAplex software was used to select the most likely trans-acting target genes based on RNA duplex energy. RNAplex duplex energy parameter was set at ≤−30.
| Gene Ontology (GO) and pathway analysis
The Shanghai Biotechnology Corporation performed the GO analysis.
The Fisher exact test was performed using cluster Profiler packages from R/Bioconductor. Pathway enrichment analysis was conducted using the SAS pathway enrichment suite (Shanghai Biotechnology, Corporation, Shanghai, China), which incorporates three pathway databases, Kyoto Encyclopedia of Genes and Genomes (KEGG),
Pathway Interaction Database (PID) and Biocarta and uses genes with an FC ≥ 2.0. Significantly enriched GO terms and pathways were defined as those with P values <.05, and significantly differentially expressed genes were defined as those with P values ≥2.
| Validation by RT-qPCR and statistical analysis
RT-qPCR was performed using ReverTra Ace® qPCR RT Master Mix with gDNA Remover (Toyobo, Osaka, Japan) according to the manufacturer's recommendations. LncRNA expression was measured by real-time RT-PCR using ABI Power SYBR Green PCR Master Mix (ABI, Foster City, CA, USA) on a 7900 HT Sequence Detection System (ABI). Specific primers for lncRNAs and mRNAs are listed in Tables S1 and S2. Relative fold change was calculated using the 2 −ΔΔCt method normalized to GAPDH. Differences in lncRNA and mRNA expression between H11-treated cells and control cells were analysed using the paired t test. P values <.05 were considered statistically significant. All of the experiments were performed in triplicate.
| Analysis of the lncRNA-mRNA co-expression network
The lncRNA-mRNA co-expression network was designed based on correlations between differentially expressed lncRNAs and mRNAs, which were based on changes in their gene expressions. For each mRNA-lncRNA, mRNA-mRNA or lncRNA-lncRNA pair, we calculated
Pearson correlation coefficients and pairs with absolute values ≥0.995
and P values <.0001 were selected to diagram the network using the program Cytoscape, which determines the number of genes related to key lncRNAs or mRNAs. The larger the node, the higher the number of gene interactions.
| Data analysis
Data were expressed as the mean ± SD of three independent experiments with three biological replicates. Statistical analysis was performed using SPSS V.17.0 (SPSS, Chicago, USA 
| RESULTS
| Expression profiles of lncRNAs and mRNAs after H11 treatment
We found 135 lncRNAs and 87 mRNAs differentially expressed in the H11-treated group when compared with the control group. Of the 135 differentially expressed lncRNAs, 56 were upregulated (Table   S3 ) and 67 were downregulated (Table S4 ). Of the 87 differentially expressed mRNAs, 43 were upregulated (Table S5 ) and 44 were downregulated (Table S6 ). Lnc-C17orf108-2:1 was the most upregulated and lnc-AE000662.92.1-10:33 was the most downregulated of the differentially expressed lncRNAs. NM_014143 (CD274) was the most upregulated and NM_001301036 (TMCC3) was the most downregulated of the differentially expressed mRNAs. The microarray data of the differentially expressed lncRNAs and mRNAs are displayed in a scatter plot ( Figure 1A ,B) and a volcano plot ( Figure 1C,D) .
Hierarchical clustering analysis was performed to group lncRNAs and mRNAs. The heatmap shows the relationship of lncRNA expression profiles ( Figure 1E ) and the mRNA expression profiles ( Figure 1F ) in the H11-treated and control groups.
| LncRNA classification and subgroup analysis
We classified the 61 upregulated lncRNAs and the 74 downregulated lncRNAs according to their genome location and context. As shown in Figure 2A ,B, of the exonic sense lncRNAs, 15 were upregulated and 10 were downregulated when compared with the control group. Of the exonic antisense lncRNAs, 9 were upregulated and 9 were downregulated. Of the intronic sense lncRNAs, 1 was upregulated and 5
were downregulated. Of the intronic antisense lncRNAs, 4 were upregulated and 9 were downregulated. Of the bidirectional lncRNAs, 6
were upregulated and 1 was downregulated. Of the intergenic lncR- 
| GO and pathway analysis of differentially expressed lncRNAs
Increasingly, it has been shown that lncRNAs are involved in multiple biological processes, including cell growth, cell cycle control, To gain further insights into the anti-HBV mechanism of H11, a signalling pathway enrichment analysis was performed using three pathways databases, KEGG, PID and Biocarta. The top ten enriched pathways were the Jak-STAT signalling pathway, the p53 signalling 
| GO and pathway analysis of differentially expressed mRNAs
Differentially expressed mRNAs were analysed by GO to determine their molecular function, biological processes and cellular compo- The analysis showed that regulation of nuclear β-catenin signalling and target gene transcription, mineral absorption, steroid hormone biosynthesis, direct p53 effectors, peroxisome proliferator-activated receptors (PPAR) signalling pathway and suggested that peroxisome pathways may be involved in this inhibition ( Figure 4B ).
| qRT-PCR validation
To validate the microarray results, 9 lncRNAs and 14 mRNAs, which were identified as being involved in HBV infection or hepatocellular carcinoma via construction of the lncRNA-mRNA co-expression network, were selected for qRT-PCR analysis of their expression. The qPCR results indicated that the lncRNAs NR_119376, ENST00000457253, NR_027242 and ENST00000612689 were upregulated, whereas NR_046371, ENST00000441146, NR_015379, ENST00000571933
and ENST00000453395 were downregulated in the H11-treated when compared with the control group ( Figure 5A ). The expression of EGR1, MT1G, TMOD2, PTGES, ARRB1 and WT1 in the H11-treated group increased, whereas expression of ACSL6, ANKRD1, CYP3A7, APOA5, CYR61, SPP1, DKK1 and SAA4 decreased when compared with the control group ( Figure 5B ). The qPCR results were concordant with the microarray data.
| Establishment of the gene co-expression network
To investigate the associations of 135 differentially expressed lncRNAs with 87 differentially expressed mRNAs, an lncRNA-mRNA coexpression network was constructed. There were 96 nodes in the network, including 51 lncRNA nodes and 45 mRNA nodes ( Figure 6 ). 
| DISCUSSION
H11 is a novel inhibitor of La protein that was identified from a screen for anti-HBV drugs, and H11 shows anti-HBV activity 13 ; however, the mechanism of action of H11 has not been fully elucidated. In this study, we used microarray analysis to identify differentially expressed lncRNAs and mRNAs in cells treated with and without H11. We used GO and KEGG analyses to identify the functions that the differentially expressed lncRNAs and mRNAs were involved in and to identify the putative biological events and signalling pathways involved in H11-mediated inhibition of HBV replication. We also constructed an lncRNA-mRNA co-expression network to investigate the putative functions of the lncRNAs. The expression data from qRT-PCR analyses of fourteen selected mRNAs, which may be involved in the PPAR F I G U R E 2 Classification of the upregulated lncRNAs (A) and downregulated lncRNAs (B) in H11-treated and control groups singling pathway, were consistent with the microarray data indicating that the lncRNAs chip analysis was highly credible.
In this study, we identified 56 lncRNAs that were upregulated, 67
lncRNAs that were downregulated, 43 mRNAs that were upregulated, and 44 mRNAs that were downregulated in the H11 treatment group when compared with the control group. Because we identified a large number of differentially expressed lncRNAs and mRNAs in our samples, we hypothesize that H11 is involved in altering expression of various types of lncRNAs and mRNAs. Recently, lncRNAs have been shown to be potential biomarkers for HBV detection 26, 27 ; however, 
29-31
It has also been shown that the hepatitis B X protein (HBx) modulates PPARγ expression and activation, which may function in steatosis. The differentially expressed lncRNAs and mRNAs are likely involved in Wnt signalling, the PPAR signalling pathway and peroxisome pathways.
F I G U R E 6
The lncRNA-mRNA co-expression network. Square nodes represent lncRNAs, and circular nodes represent mRNAs. The lines between nodes represent interactions between two genes. Red nodes indicate upregulated genes, and green nodes indicate downregulated genes. Degree is defined as the numbers of links one node has to the other nodes
